Abstract
BackgroundMalaria is causing more than half of a million deaths and 214 million clinical cases annually. Despite tremendous efforts for the control of malaria, the global morbidity and mortality have not been significantly changed in the last 50 years. Artemisinin, extracted from the medicinal plant Artemisia sp. is an effective anti-malarial drug. In 2015, elucidation of the effectiveness of artemisinin as a potent anti-malarial drug was acknowledged with a Nobel prize. Owing to the tight market and low yield of artemisinin, an economical way to increase its production is to increase its content in Artemisia sp. through different biotechnological approaches including genetic transformation.MethodsArtemisia annua and Artemisia dubia were transformed with rol ABC genes through Agrobacterium tumefacienes and Agrobacterium rhizogenes methods. The artemisinin content was analysed and compared between transformed and untransformed plants with the help of LC–MS/MS. Expression of key genes [Cytochrome P450 (CYP71AV1), aldehyde dehydrogenase 1 (ALDH1), amorpha-4, 11 diene synthase (ADS)] in the biosynthetic pathway of artemisinin and gene for trichome development and sesquiterpenoid biosynthetic (TFAR1) were measured using Quantitative real time PCR (qRT-PCR). Trichome density was analysed using confocal microscope.ResultsArtemisinin content was significantly increased in transformed material of both Artemisia species when compared to un-transformed plants. The artemisinin content within leaves of transformed lines was increased by a factor of nine, indicating that the plant is capable of synthesizing much higher amounts than has been achieved so far through traditional breeding. Expression of all artemisinin biosynthesis genes was significantly increased, although variation between the genes was observed. CYP71AV1 and ALDH1 expression levels were higher than that of ADS. Levels of the TFAR1 expression were also increased in all transgenic lines. Trichome density was also significantly increased in the leaves of transformed plants, but no trichomes were found in control roots or transformed roots. The detection of significantly raised levels of expression of the genes involved in artemisinin biosynthesis in transformed roots correlated with the production of significant amounts of artemisinin in these tissues. This suggests that synthesis is occurring in tissues other than the trichomes, which contradicts previous theories.ConclusionTransformation of Artemisia sp. with rol ABC genes can lead to the increased production of artemisinin, which will help to meet the increasing demand of artemisinin because of its diverse pharmacological and anti-malarial importance.
Highlights
Malaria is causing more than half of a million deaths and 214 million clinical cases annually
Three independent transgenic lines of Artemisia annua (A1, A2, and A3) and Artemisia dubia (D1, D2 and D3) were obtained by transformation with Agrobacterium tumefacienes and two independent transgenic lines of hairy roots were obtained by transformation with Agrobacterium rhizogenes (AH1 and AH2 of Artemisia annua and DH1 and DH2 of Artemisia dubia) carrying rol ABC genes (Fig. 2)
The results confirmed the integration of the Agrobacterium T-DNA in the genome of Artemisia annua and Artemisia dubia transgenic lines
Summary
Malaria is causing more than half of a million deaths and 214 million clinical cases annually. Artemisinin is a sesquiterpene lactone which has been reported to be produced within the glandular trichomes of Artemisia annua, a member of the Asteraceae family This plant is endemic to China and has been used there for over 2000 years to treat fever [2, 3]. Artemisinin and its derivatives are used in combination therapies for the treatment of malaria [8], and for the treatment of a number of cancers and viral diseases [9, 10] These therapies are not available to millions of the world’s poorest people because of the low yield of artemisinin in naturally growing Artemisia plants (0.1 to 0.5 % of dry weight) [11]. One approach is to optimize production though modification of the metabolic pathways involved, this could be through selection for beneficial alleles or through genetic transformation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.